Discussion on predictors of response to infliximab in patients with Crohn's disease

被引：3
|
作者：
Hommes, D [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 07期
关键词：
D O I：
10.1016/S0016-5085(03)00575-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2002 / 2003
页数：2
相关论文
共 50 条
  • [41] An open label study of adalimumab in Crohn's disease patients with a loss of response to infliximab
    Anwar, Malik
    O'Sullivan, Maria
    Ryan, Barbara
    Breslin, Niall
    O'Connor, Humphrey
    O'Morain, Colm
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A662 - A662
  • [42] Flexibility in interval and dosing of infliximab enables maintained response of patients with Crohn's disease
    Schnitzler, Fabian
    Fidder, Herma
    Ferrante, Marc
    Noman, Maja
    Van Assche, Gert A.
    Hoffman, Ilse
    Vermeire, Severine
    Rutgeerts, Paul J.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A658 - A658
  • [43] Gene Signature-based Prediction of Infliximab Response in Patients with Crohn?s Disease
    Li, Jianhui
    Zhao, Jingyi
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (03): : 507 - 515
  • [44] A Novel Mechanistic Biomarker Panel Predicts Response to Infliximab in Patients with Crohn's Disease
    Macoritto, Michael
    Hoang, Vy
    Thomson, Ty
    Laifenfeld, Daphna
    Selventa, David Drubin
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 : S61 - S61
  • [45] Optimising response to infliximab in the management of perianal Crohn's disease
    Shah, R.
    Anandbaskaran, S.
    Hart, A.
    Tozer, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I471 - I472
  • [46] Optimising response to infliximab in the management of perianal Crohn's disease
    Shah, R.
    Anandbaskaran, S.
    Hart, A.
    Tozer, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I471 - I472
  • [47] Hidradenitis suppurativa and Crohn's disease:: Response to treatment with infliximab
    Martínez, F
    Nos, P
    Benlloch, S
    Ponce, J
    [J]. INFLAMMATORY BOWEL DISEASES, 2001, 7 (04) : 323 - 326
  • [48] Lack of adherence to infliximab in inflammatory bowel disease patients contributes to loss of response in Crohn's disease
    Ferreiro Iglesias, R.
    Gonzalez-Lopez, J.
    Calvino-Suarez, C.
    Mauriz-Barreiro, V.
    Baston-Rey, I.
    Cruz, R.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S518 - S519
  • [49] Predictors of Disability in Patients with Crohn's Disease
    Patil, Seema
    Rustgi, Ankur
    Watson, Joshua
    Betteridge, John
    Szeto, Winnie
    Cheevers, Nadia
    Flasar, Mark
    Skup, Martha
    Yang, Mei
    Chao, Jingdong
    Mulani, Parvez
    Cross, Raymond
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S651 - S651
  • [50] Predictors of response to medical treatment in Crohn's disease patients with intestinal obstruction
    Ben Mustapha, N.
    Labidi, A.
    Serghini, M.
    Kardous, Y.
    Fekih, M.
    Boubaker, J.
    Filali, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S223 - S224
12345